KalVista Pharmaceuticals, Inc.
KALV
$14.66
$1.148.43%
NASDAQ
| 09/30/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.47% | -13.21% | -12.87% | -- | -- |
| Total Receivables | 9.60% | -57.08% | 61.04% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.00% | 33.73% | 24.78% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 57.96% | -14.81% | -9.60% | 75.59% | -20.54% |
|
|
|||||
| Total Current Assets | 57.96% | -14.81% | -9.60% | 75.59% | -20.54% |
| Net Property, Plant & Equipment | 69.88% | -3.98% | 3.93% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.77% | 53.55% | 11.61% | -- | -- |
| Total Assets | 57.74% | -14.06% | -9.14% | 71.60% | -19.66% |
|
|
|||||
| Total Accounts Payable | 37.57% | 20.19% | -16.62% | -- | -- |
| Total Accrued Expenses | 9.47% | -30.53% | 49.10% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 122.24% | 7.33% | 36.91% | -- | -- |
| Total Finance Division Other Current Liabilities | 0.87% | 3.75% | -- | -- | -- |
| Total Other Current Liabilities | 0.87% | 3.75% | -- | -- | -- |
| Total Current Liabilities | 17.44% | -15.04% | 76.33% | 15.57% | -1.10% |
|
|
|||||
| Total Current Liabilities | 17.44% | -15.04% | 76.33% | 15.57% | -1.10% |
| Long-Term Debt | 103.09% | 24.97% | 4.92% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 127.12% | -7.18% | -0.18% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 84.83% | 12.44% | 18.73% | 387.60% | -2.04% |
|
|
|||||
| Common Stock & APIC | 0.31% | 0.88% | 0.73% | -- | -- |
| Retained Earnings | -3.62% | -9.20% | -8.69% | -8.78% | -8.29% |
| Treasury Stock & Other | -5.35% | -22.50% | -136.14% | -- | -- |
| Total Common Equity | -58.33% | -57.24% | -34.27% | 8.31% | -22.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -58.33% | -57.24% | -34.27% | 8.31% | -22.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -58.33% | -57.24% | -34.27% | -- | -- |
|
|
|||||